Page last updated: 2024-11-03

risperidone and Hypopituitarism

risperidone has been researched along with Hypopituitarism in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Hypopituitarism: Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haverkort, S1
Jellesma-Eggenkamp, MJ1
Marijnissen, RM1

Other Studies

1 other study available for risperidone and Hypopituitarism

ArticleYear
[Psychiatric presentation of hypopituitarism in an elderly patient].
    Tijdschrift voor psychiatrie, 2007, Volume: 49, Issue:2

    Topics: Aged, 80 and over; Antipsychotic Agents; Brain Injuries; Female; Humans; Hydrocortisone; Hypopituita

2007